PASADENA, CA--(Marketwired - Sep 27, 2016) - Prolacta Bioscience®, the nation's leading provider of human milk-based neonatal nutritional products, announced today that it has assembled a Scientific Advisory Board (SAB). The SAB convened for its inaugural meeting during the 4th Annual International Conference on Human Milk Science and Innovation in Pasadena, Calif., on Sept. 7, 2016.
Introduced by Scott Elster, President and CEO, and Dr. Victoria Niklas, Chief Medical and Scientific Officer at Prolacta Bioscience, the SAB will help to guide expansion in research and development and to highlight discoveries that underlie the extended health benefits of human milk.
"The formation of the Scientific Advisory Board is the next step in Prolacta's long-standing mission to advance the science of human milk, so the International Conference on Human Milk Science and Innovation was the ideal place to commence its endeavors," said Dr. Niklas. "We are excited about the forward-looking prospects that the esteemed members of this team can deliver across a broad range of scientific research fields."